Sort
82,697 grants matching “vaccine development”
REDES: a peer network and mobile health (mHealth) enhanced CHW model to maximize COVID-19 vaccination among low income Latinos
$736,844Kathleen R Page · Johns Hopkins University · R01 · FY2022 · MD
NONHUMAN PRIMATE CORE QUANT IRAL RNA LABORATORY FOR AIDS VACCINE R&D
$736,840Ranajit Pal · Advanced Bioscience Laboratories, Inc. · N01 · FY2017 · AI
Establishment of Specific Free Rhesus and Pigtail Macques Colonies
$736,830Michael K Axthelm · Oregon Health & Science University · U24 · FY2015 · OD
Broadly Specific Needle-Free Vaccines against Emerging and Biothreat Viruses
$736,800Alexander Bukreyev · University Of Texas Med Br Galveston · R01 · FY2014 · AI
Biology of the Eosinophilic Leukocyte
$736,753Helene Rosenberg · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
The VesiVax® System: Vaccine Development Made Easy
$736,747Samon Ho · Molecular Express, Inc. · R44 · FY2017 · AI
The Genomics and Antagonism of Pathobiont Colonization
$736,728Anthony W Maresso · Baylor College Of Medicine · U19 · FY2021 · AI
LDLRAD3 Receptor Interaction with Venezuelan Equine Encephalitis Virus
$736,692Michael S. Diamond · Washington University · R01 · FY2021 · AI
The Consequences of Reinfection with M. tuberculosis
$736,682Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · AI
Using Lipids for Vaccination
$736,674Luc Teyton · Scripps Research Institute, The · U01 · FY2008 · AI
REDES: a peer network and mobile health (mHealth) enhanced CHW model to maximize COVID-19 vaccination among low income Latinos
$736,639Kathleen R Page · Johns Hopkins University · R01 · FY2023 · MD
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
$736,637Chaoyang Xue · Rutgers Biomedical And Health Sciences · R01 · FY2025 · AI
Task A05: Small animal models for cytomegalovirus and herpes simplex viruses
$736,623David Bernstein · Cincinnati Childrens Hosp Med Ctr · N01 · FY2018 · AI
Prospective intergenerational mixed-methods investigation of the short- and long-term impact of COVID-19 on adolescent mental, social, and behavioral health
$736,560Jeff R Temple · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · MH
Inflammation and Therapy for Respiratory Virus Infection
$736,532Helene Rosenberg · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
A Genomic Approach to Parasites From the Phylum Nematoda
$736,487Richard K. Wilson · Washington University · U01 · FY2006 · AI
Development of novel HIV Env vaccines to augment B lymphocyte responses via delivery of stabilized well-ordered Env spikes for comparative evaluation in preclinical immunogenicity and efficacy studies
$736,467Christopher Parks · International Aids Vaccine Initiative · P01 · FY2017 · AI
A Second-Generation Patch Test for Tuberculosis
$736,439Sequella, Inc. · U01 · FY2005 · AI
Vanderbilt Vaccine and Treatment Evaluation Unit
$736,417Clarence Buddy Creech · Vanderbilt University Medical Center · UM1 · FY2020 · AI
Novel Pathogen Associated Cancers (PQ12)
$736,412Denise A. Galloway · Fred Hutchinson Cancer Research Center · R01 · FY2013 · CA
Impact of Extraordinarily Large Numbers of SIV-specific CD8 T Cells on Vaginal Tr
$736,366David Masopust · University Of Minnesota · R01 · FY2012 · AI
REstoring mental health after COVID-19 through commUnity-based Psychological services in New York City (RECOUP-NY)
$736,334Brandon Alan Kohrt · George Washington University · R01 · FY2023 · MH
Protective role of V2 antibodies induced at mucosal tissues in macaques
$736,300Miroslaw K Gorny · New York University School Of Medicine · R01 · FY2017 · AI
IgM in the regulation of TB immunity
$736,298John R. Chan · Rutgers Biomedical And Health Sciences · R01 · FY2023 · AI
Eliciting lung-localized CD4 T cell responses against Mycobacterium tuberculosis in preventive and post-exposure settings
$736,246Kevin B Urdahl · Seattle Children'S Hospital · R01 · FY2018 · AI